Reliable EGFR mutation testing in ultrasound-guided supraclavicular lymph node fine-needle aspirates: a cohort study with diagnostic performance analysis.

about

Reliable EGFR mutation testing in ultrasound-guided supraclavicular lymph node fine-needle aspirates: a cohort study with diagnostic performance analysis.

Item

http://www.wikidata.org/entity/Q35808309

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reliable EGFR mutation testing ...... agnostic performance analysis.

@ast

Reliable EGFR mutation testing ...... agnostic performance analysis.

@en

type

Item

label

Reliable EGFR mutation testing ...... agnostic performance analysis.

@ast

Reliable EGFR mutation testing ...... agnostic performance analysis.

@en

prefLabel

Reliable EGFR mutation testing ...... agnostic performance analysis.

@ast

Reliable EGFR mutation testing ...... agnostic performance analysis.

@en

P1476

Reliable EGFR mutation testing ...... agnostic performance analysis.

@en

P2093

David R Baldwin

http://www.w3.org/2001/XMLSchema#string

Maruti Kumaran

http://www.w3.org/2001/XMLSchema#string

Sandeep Tiwari

http://www.w3.org/2001/XMLSchema#string

Vishakha Sovani

http://www.w3.org/2001/XMLSchema#string

P2860

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

Ultrasound guided cytological aspiration of supraclavicular lymph nodes in patients with suspected lung cancer.

Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group

Challenges of detecting EGFR T790M in gefitinib/erlotinib-resistant tumours.

EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities.

The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC.

EGFR-mutated oncogene-addicted non-small cell lung cancer: current trends and future prospects.

P304

e000075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJRESP-2014-000075

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amir Awwad

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279485325

http://www.w3.org/2001/XMLSchema#string

P698

26175906

http://www.w3.org/2001/XMLSchema#string

P932

4488608

http://www.w3.org/2001/XMLSchema#string